Christoph Boesecke

8.4k total citations · 1 hit paper
141 papers, 2.8k citations indexed

About

Christoph Boesecke is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Christoph Boesecke has authored 141 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Epidemiology, 77 papers in Hepatology and 68 papers in Infectious Diseases. Recurrent topics in Christoph Boesecke's work include Hepatitis C virus research (75 papers), Liver Disease Diagnosis and Treatment (40 papers) and HIV/AIDS drug development and treatment (39 papers). Christoph Boesecke is often cited by papers focused on Hepatitis C virus research (75 papers), Liver Disease Diagnosis and Treatment (40 papers) and HIV/AIDS drug development and treatment (39 papers). Christoph Boesecke collaborates with scholars based in Germany, United Kingdom and Spain. Christoph Boesecke's co-authors include Jürgen K. Rockstroh, Carolynne Schwarze‐Zander, Hans‐Jürgen Stellbrink, Patrick Ingiliz, Heiko Jessen, Jan‐Christian Wasmuth, Axel Baumgarten, Christoph D. Spinner, Jacob Nattermann and Stefan Mauss and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Christoph Boesecke

138 papers receiving 2.8k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023

2023 75 citations Juan Ambrosioni, Laura Levi et al. HIV Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christoph Boesecke Germany	29	1.5k	1.4k	1.1k	679	426	141	2.8k
Cristina Tural Spain	33	2.0k 1.4×	2.0k 1.5×	1.9k 1.7×	1.2k 1.8×	514 1.2×	114	3.8k
Andrzej Horban Poland	34	2.4k 1.7×	2.1k 1.5×	2.2k 2.0×	1.2k 1.8×	504 1.2×	183	4.6k
Juan González‐García Spain	27	1.9k 1.3×	1.7k 1.2×	1.7k 1.6×	790 1.2×	660 1.5×	165	3.5k
Kathy Petoumenos Australia	30	1.9k 1.3×	1.6k 1.2×	944 0.9×	930 1.4×	1.0k 2.4×	133	3.7k
M. Elaine Eyster United States	34	2.1k 1.5×	1.5k 1.1×	1.7k 1.6×	1.1k 1.7×	253 0.6×	124	5.1k
Luís F. López‐Cortés Spain	29	1.5k 1.0×	1.4k 1.0×	1.1k 1.0×	631 0.9×	316 0.7×	155	2.8k
Katherine Huppler Hullsiek United States	31	1.1k 0.8×	1.6k 1.2×	328 0.3×	1.2k 1.8×	672 1.6×	52	2.9k
Clifford Leen United Kingdom	31	1.1k 0.8×	1.7k 1.2×	400 0.4×	1.1k 1.6×	751 1.8×	117	2.8k
Claudine Duvivier France	30	1.2k 0.8×	1.4k 1.0×	404 0.4×	1.0k 1.5×	569 1.3×	110	2.7k
Isabelle Poizot‐Martin France	31	1.2k 0.8×	1.6k 1.2×	406 0.4×	1.1k 1.6×	805 1.9×	154	3.2k

Countries citing papers authored by Christoph Boesecke

Since Specialization

Citations

This map shows the geographic impact of Christoph Boesecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Boesecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Boesecke more than expected).

Fields of papers citing papers by Christoph Boesecke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Boesecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Boesecke. The network helps show where Christoph Boesecke may publish in the future.

Co-authorship network of co-authors of Christoph Boesecke

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Boesecke. A scholar is included among the top collaborators of Christoph Boesecke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Boesecke. Christoph Boesecke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parczewski, Miłosz, Christoph Boesecke, Pavel Khaykin, et al.. (2025). Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response. AIDS. 39(6). 629–638. 1 indexed citations

Boesecke, Christoph, Axel Baumgarten, Christian Hoffmann, et al.. (2024). Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men. Infection. 53(1). 61–70. 5 indexed citations

Krings, Amrei, Christian Kollan, Daniel Schmidt, et al.. (2024). Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999–2023). Infection. 53(3). 1013–1028.

Bremen, Kathrin van, Miłosz Parczewski, Malte B. Monin, et al.. (2024). HIV Care in Ukrainian Migrants in Two European Countries: All the Same?. Pathogens. 13(8). 621–621. 1 indexed citations

Ambrosioni, Juan, Laura Levi, Jasmini Alagaratnam, et al.. (2023). Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV Medicine. 24(11). 1126–1136. 75 indexed citations breakdown →

Hentrich, Marcus, et al.. (2023). Enabling CAR T‐cell therapies for HIV‐positive lymphoma patients – A call for action. HIV Medicine. 24(9). 957–964. 11 indexed citations

Boesecke, Christoph, et al.. (2023). Prevalence, characteristics and challenges of late HIV diagnosis in Germany: an expert narrative review. Infection. 51(5). 1223–1239. 11 indexed citations

Brehm, Thomas Theo, Timo Wolf, Christoph Boesecke, et al.. (2023). Tecovirimat for the treatment of severe Mpox in Germany. Infection. 51(5). 1563–1568. 14 indexed citations

Monin, Malte B., Moritz Berger, Robert Mahn, et al.. (2023). Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients. Liver Cancer. 12(4). 339–355. 1 indexed citations

10.

Boesecke, Christoph, et al.. (2022). Severe monkeypox-virus infection in undiagnosed advanced HIV infection. Infection. 50(6). 1633–1634. 38 indexed citations

11.

Crowell, Trevor A., Haoyu Qian, Carsten Tiemann, et al.. (2021). Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort. AIDS Research and Therapy. 18(1). 52–52. 3 indexed citations

12.

Dold, Leona, Mette Juul Nielsen, Michael Praktiknjo, et al.. (2019). Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART. PLoS ONE. 14(7). e0219526–e0219526. 7 indexed citations

13.

Malin, Jakob J, Christoph Boesecke, Carolynne Schwarze‐Zander, et al.. (2019). Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection. HIV Medicine. 20(3). 230–236. 13 indexed citations

14.

Ryom, Lene, Christoph Boesecke, Margherita Bracchi, et al.. (2018). Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0. HIV Medicine. 19(5). 309–315. 100 indexed citations

15.

Goeser, Felix, A Glässner, P Kokordelis, et al.. (2015). HIV mono-infection is associated with an impaired anti-HCV activity of NK cells. AIDS. 1–1. 6 indexed citations

16.

Boesecke, Christoph & Emma Page. (2015). Direct-acting antiviral-based therapy for acute hepatitis C coinfection. Current Opinion in HIV and AIDS. 10(5). 330–336. 3 indexed citations

17.

Steiner, Sabine, Mattias Mandorfer, Robert Straßl, et al.. (2014). Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C coinfected patients in a real-world setting. Zeitschrift für Gastroenterologie. 52(5). 56. 2 indexed citations

18.

Mandorfer, Mattias, B.A. Payer, Maximilian C. Aichelburg, et al.. (2014). Therapeutic Potential of and Treatment with Boceprevir/Telaprevir-Based Triple-Therapy in HIV/Chronic Hepatitis C Co-Infected Patients in a Real-World Setting. AIDS Patient Care and STDs. 28(5). 221–227. 8 indexed citations

19.

Boesecke, Christoph & Sarah Pett. (2012). Clinical studies with chemokine receptor-5 (CCR5)-inhibitors. Current Opinion in HIV and AIDS. 7(5). 456–462. 17 indexed citations

20.

Rodger, Alison, Zoë Fox, Jens Lundgren, et al.. (2009). Activation and Coagulation Biomarkers Are Independent Predictors of the Development of Opportunistic Disease in Patients with HIV Infection. The Journal of Infectious Diseases. 200(6). 973–983. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact